222 related articles for article (PubMed ID: 22040067)
1. A false sense of security? The U.S. Food and Drug Administration's framework for evaluating new supplement ingredients.
Cohen PA
Antioxid Redox Signal; 2012 Mar; 16(5):458-60. PubMed ID: 22040067
[TBL] [Abstract][Full Text] [Related]
2. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
Gibson JE; Taylor DA
J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
[TBL] [Abstract][Full Text] [Related]
3. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
4. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
Dodge T; Kaufman A
Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
[TBL] [Abstract][Full Text] [Related]
5. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
McNamara SH
Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
[No Abstract] [Full Text] [Related]
6. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
7. Under the law, FDA must grant different standards for new dietary ingredients and food additives.
Mister S; Hathcock J
Regul Toxicol Pharmacol; 2012 Apr; 62(3):456-8. PubMed ID: 22310217
[TBL] [Abstract][Full Text] [Related]
8. Marketing dietary supplements in the United States: a review of the requirements for new dietary ingredients.
Noonan C; Patrick Noonan W
Toxicology; 2006 Apr; 221(1):4-8. PubMed ID: 16497425
[TBL] [Abstract][Full Text] [Related]
9. Dietary supplements and their future in health care: commentary on draft guidelines proposed by the Food and Drug Administration.
Umhau JC; Garg K; Woodward AM
Antioxid Redox Signal; 2012 Mar; 16(5):461-2. PubMed ID: 22181059
[TBL] [Abstract][Full Text] [Related]
10. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
Silverglade BA
Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
[No Abstract] [Full Text] [Related]
11. The impact of cGMP compliance on consumer confidence in dietary supplement products.
Crowley R; FitzGerald LH
Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
[TBL] [Abstract][Full Text] [Related]
12. Dietary Supplements Pose Real Dangers to Patients.
White CM
Ann Pharmacother; 2020 Aug; 54(8):815-819. PubMed ID: 31973570
[TBL] [Abstract][Full Text] [Related]
13. Consumers' perceptions of the dietary supplement health and education act: implications and recommendations.
Dodge T
Drug Test Anal; 2016; 8(3-4):407-9. PubMed ID: 27072844
[TBL] [Abstract][Full Text] [Related]
14. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs).
Pawar RS; Grundel E
Drug Test Anal; 2017 Mar; 9(3):500-517. PubMed ID: 27259162
[TBL] [Abstract][Full Text] [Related]
15. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
16. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
Brown AC
Food Chem Toxicol; 2017 Sep; 107(Pt A):449-471. PubMed ID: 27818322
[TBL] [Abstract][Full Text] [Related]
17. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings.
Tucker J; Fischer T; Upjohn L; Mazzera D; Kumar M
JAMA Netw Open; 2018 Oct; 1(6):e183337. PubMed ID: 30646238
[TBL] [Abstract][Full Text] [Related]
18. Petition to request an exemption from 100 percent identity testing of dietary ingredients: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. Interim final rule.
Food and Drug Administration, HHS
Fed Regist; 2007 Jun; 72(121):34959-69. PubMed ID: 17674485
[TBL] [Abstract][Full Text] [Related]
19. The history of efforts to regulate dietary supplements in the USA.
Swann JP
Drug Test Anal; 2016; 8(3-4):271-82. PubMed ID: 26593452
[TBL] [Abstract][Full Text] [Related]
20. Drug safety. IOM recommends action on dietary supplements.
Stokstad E
Science; 2004 Apr; 304(5668):188. PubMed ID: 15073343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
